Ontunisertib is an investigational new drug that is being evaluated by Agomab Spain S.L.U. for the treatment of fibrostenotic Crohn's Disease. It is a TGF beta receptor 1 (ALK5) antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.